The international exchanges and cooperation in medical industry is of significant importance for the well-being of human lives worldwide, especially in this unconventional time for fighting against COVID-19 pandemic globally. As of the frontline for tackling the challenges and safeguarding public health in the post-coronavirus era, dialogues and exchanges in the field of China-Germany medicine and health care industry are of crucial necessity to the active and comprehensive promotion of in-depth cooperation between China and Germany.

Under this status quo, Sichuan International Medical Exchange & Promotion Association (SCIMEA) has organized the 2020 China-Germany Night of Medical Exchange-China-Germany Top Medical Industry Dialogue on 21st August 2020 as to gather up stakeholders and key players in the medical and health care industry in Sichuan Province and Germany, aiming to promote joint discussions on the current trend and future prospects of the China-Germany healthcare industry by establishing a high-end dialogue platform via online and offline interaction.

This event has attracted 115 distinguished guests, including Consul from Consulate General of Germany in Chengdu and 3 more representatives from German State Offices, Chambers, etc., more than 30 officials from Chinese provincial and municipal administrative offices and healthcare industrial parks, 22 top medical experts from West China Hospital, West China College of Stomatology, Affiliated Hospital of Chengdu University of TCM, National Clinical Center for Geriatrics Diseases, etc. And more than 30 heads of prominent medical clusters like Medical Valley, BIO.NRW as well as CEOs and senior managers of top pharmaceutic enterprises from both German and Chinese sides such as Bayer, Frsenius Kabi, Boehringer Ingelheim, Easton Biopharmaceuticals, Shifeng Medical Apparatus & Instrument, Kelun Group and Lvye Pharma Group, etc. have attended this top activity.

Following the event, feedback on medical exchanges is emerging in large numbers from SCIMEA’s members. In terms of hospital development, those frequently mentioned are e introduction of medical instrument, overseas training for medicalspecialists, establishing training school in close cooperation with German experts, etc. As for medical industry cooperation, some German companies are looking forward to contacting top Chinese expert members of SCIMEA and some SCIMEA company members are showing strong interests in importing medical products or having strategic cooperation with foreign counterparts. 

SCIMEA will continue being the top comprehensive platform for all the stakeholders in the medical industry and proactively promoting the industrial development in the post-epidemic era.